Stay updated on Dose Ranging Study of PF-06700841 Cream in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Dose Ranging Study of PF-06700841 Cream in Atopic Dermatitis Clinical Trial page.

Latest updates to the Dose Ranging Study of PF-06700841 Cream in Atopic Dermatitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 on the page footer.SummaryDifference0.0%

- Check19 days agoChange DetectedMinor metadata update: the page revision changed from v3.4.0 to v3.4.1; no impact on study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.0%

- Check69 days agoChange DetectedNew study sites were added across multiple US states and internationally (New South Wales, Victoria, Manitoba, Ontario, Quebec, Hokkaido, Osaka, Tokyo) with revision to v3.3.3. The prior location list (v3.3.2) and the HHS Vulnerability Disclosure entry were removed.SummaryDifference2%

- Check91 days agoChange DetectedA new revision label 'Revision: v3.3.2' has been added and the previous label 'Revision: v3.2.0' has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check98 days agoChange DetectedNotice about government funding lapse removed from the page. Core study information including objectives, design, outcomes, and locations remains unchanged.SummaryDifference0.2%

Stay in the know with updates to Dose Ranging Study of PF-06700841 Cream in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose Ranging Study of PF-06700841 Cream in Atopic Dermatitis Clinical Trial page.